| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/02/2006 | US20060024373 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 02/02/2006 | US20060024372 High viscosity antibacterials |
| 02/02/2006 | US20060024371 Crosslinking a protein with derivative of a hydrophilic polymer with a functionality of at least three to form a non-liquid hydrogel and incorporating a therapeutic agent; the hydrogel degrades over time back to a liquid form |
| 02/02/2006 | US20060024370 Modafinil oral lyophilizate |
| 02/02/2006 | US20060024369 Chlorine dioxide releasing composite article |
| 02/02/2006 | US20060024368 Compressed composite delivery system for release-rate modulation of bioactives |
| 02/02/2006 | US20060024367 Controlled release alpha lipoic acid formulation with an inositol compound |
| 02/02/2006 | US20060024366 Modified release compositions of milnacipran |
| 02/02/2006 | US20060024365 Novel dosage form |
| 02/02/2006 | US20060024364 Directly compressible formulations of azithromycin |
| 02/02/2006 | US20060024363 Directly compressible formulations of azithromycin |
| 02/02/2006 | US20060024362 Composition comprising a benzimidazole and process for its manufacture |
| 02/02/2006 | US20060024361 Disintegrant assisted controlled release technology |
| 02/02/2006 | US20060024360 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof |
| 02/02/2006 | US20060024359 Drug delivery system and method |
| 02/02/2006 | US20060024357 Wound healing polymer compositions and methods for use thereof |
| 02/02/2006 | US20060024354 A gum, lollipop and lozenge having at least two separate components, with at least one of such components containing amounts of herbal, medicinal and/or mineral elements or combinations thereof to enhance metabolism |
| 02/02/2006 | US20060024353 Novel porous film-forming granules, process for their preparation and application in the film coating of tablets and sweets |
| 02/02/2006 | US20060024336 Ion binding compositions |
| 02/02/2006 | US20060024335 Oral compositions which mask the bitter taste of a bitter-tasting agent |
| 02/02/2006 | US20060024290 prophylactic and/or therapeutic agent for the modification of fertility and behaviour patterns of animals, the achievement of livestock production gains such as increasing growth, decreasing feed conversion ratios or the control of unwanted organoleptic characteristics |
| 02/02/2006 | US20060024276 Hybrid device for cell therapies |
| 02/02/2006 | US20060024271 Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination |
| 02/02/2006 | US20060024265 Administering sodium-binding polymer of a core-shell, having an in vivo sodium binding capacity of 4 mmol or more per gram of polymer for removing sodium in gastro-intestinal tract ; treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, fluid overload |
| 02/02/2006 | US20060024247 Oral care formulations comprising highly bioavailable Coenzyme Q-10 cyclodextrin complex |
| 02/02/2006 | US20060024243 Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same |
| 02/02/2006 | US20060024242 Solubilizing liquid of refractory element and producing method thereof |
| 02/02/2006 | US20060024241 Vitamin B12 compositions |
| 02/02/2006 | US20060024240 Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
| 02/02/2006 | US20060024238 Compositions and methods using proton pump inhibitors |
| 02/02/2006 | US20060024237 Fine, warm, dripless, non-irritating spray; tasteless, odorless, non-aqueous liquid; Suitably the carrier is a cyclopentasiloxane, preferably decamethylcyclopentylsiloxane, a triglyceride, a diglyceride, and mixtures of said glycerides |
| 02/02/2006 | DE20221486U1 Tamsulosin-Tabletten mit modifizierter Freisetzung Tamsulosin tablets with modified release |
| 02/02/2006 | DE102004031550A1 Hochkonzentrierte, selbstemulgierende Emulsionsgrundlagen zur Herstellung von Öl in Wasser Emulsionen Highly concentrated, self-emulsifying emulsion bases for the production of oil in water emulsions |
| 02/02/2006 | DE10108251B4 Verabreichung eines Medikaments mittels Mikro-Verkapselung Administration of a drug by means of micro-encapsulation |
| 02/02/2006 | CA2617185A1 Skin coating composition and uses thereof |
| 02/02/2006 | CA2616670A1 Process for preparing microcrystals |
| 02/02/2006 | CA2575006A1 Dosage forms with an enterically coated core tablet |
| 02/02/2006 | CA2574828A1 Crystallization of antibodies or fragments thereof |
| 02/02/2006 | CA2574773A1 Compositions and methods for treating excessive bleeding |
| 02/02/2006 | CA2574602A1 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form |
| 02/02/2006 | CA2573705A1 Pharmaceutical multilayer tablet for controlled release of active ingredients with highly ph-dependent solubility |
| 02/02/2006 | CA2573018A1 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 02/02/2006 | CA2571926A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 02/02/2006 | CA2571045A1 Pharmaceutical formulation based on antibiotic in microcapsule form |
| 02/02/2006 | CA2570734A1 Injectable microspheres from unsaturated functionalized polyhydric alcohol esters |
| 02/02/2006 | CA2570608A1 Multiparticle pharmaceutical form for low-solubility active substances and a process for preparing the pharmaceutical form |
| 02/02/2006 | CA2570277A1 Medicament in a multilayer form |
| 02/01/2006 | EP1621569A1 Polyethylene glycol/polycation block copolymer |
| 02/01/2006 | EP1621219A2 Intraocular implants for preventing transplant rejection in the eye |
| 02/01/2006 | EP1621212A1 Formulations comprising antisense nucleotides to connexins |
| 02/01/2006 | EP1621211A1 Soft capsule film and soft capsule |
| 02/01/2006 | EP1621207A2 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors |
| 02/01/2006 | EP1621202A1 Freeze-dried preparation containing methylcobalamin and process for producing the same |
| 02/01/2006 | EP1621199A1 Remedies for diseases to be applied to eye |
| 02/01/2006 | EP1621197A2 Composition comprising a steroid and an anticholinergic agent |
| 02/01/2006 | EP1621192A1 Transdermal drug delivery formulations with optimal amounts of vasodilators therein |
| 02/01/2006 | EP1621188A1 Ultraviolet-shielding type patch |
| 02/01/2006 | EP1621187A1 Pharmaceutical multiparticulate tablet formulations and process for their preparation |
| 02/01/2006 | EP1621186A1 Modafinil oral lyophilizate |
| 02/01/2006 | EP1621077A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/01/2006 | EP1620560A1 Delivery of sirna to cells using polyampholytes |
| 02/01/2006 | EP1620537A2 Large volume ex vivo electroporation method |
| 02/01/2006 | EP1620198A1 Reactor coated with a polymer |
| 02/01/2006 | EP1620193A1 Antisolvent solidification process |
| 02/01/2006 | EP1620140A1 Injectable cross-linked polymeric preparations and uses thereof |
| 02/01/2006 | EP1620114A2 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films |
| 02/01/2006 | EP1620113A1 Topical formulation of ivermectin for the treatment of dermatological conditions |
| 02/01/2006 | EP1620111A2 Controlled release formulation of erythromycin derivatives |
| 02/01/2006 | EP1620096A2 Pellet formulations of acid-labile antiulcer benzimidazole compounds |
| 02/01/2006 | EP1620080A1 Abuse-resistant transdermal dosage form |
| 02/01/2006 | EP1620079A1 Bone targeting of biodegradable drug-containing nanoparticles |
| 02/01/2006 | EP1620078A2 Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide |
| 02/01/2006 | EP1620077A2 Oral pharmaceutical delivery system with improved sustained release |
| 02/01/2006 | EP1620076A2 Formation of strong superporous hydrogels |
| 02/01/2006 | EP1620075A2 Highly plastic granules for making fast melting tablets |
| 02/01/2006 | EP1620074A2 Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability |
| 02/01/2006 | EP1620073A1 Absorption enhancers such as e.g. bht, bha or propyl gallate |
| 02/01/2006 | EP1620072A1 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 02/01/2006 | EP1620069A2 Warning and nonirritating lubricant fungicide compositions in the form of a gel |
| 02/01/2006 | EP1620066A2 Oral care methods and products |
| 02/01/2006 | EP1620060A2 Methods and devices for the sustained release of multiple drugs |
| 02/01/2006 | EP1620059A2 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan |
| 02/01/2006 | EP1620058A2 Composition for improving cognition and memory |
| 02/01/2006 | EP1620056A2 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 02/01/2006 | EP1620039A2 Magnetically controllable drug and gene delivery stents |
| 02/01/2006 | EP1620038A2 Drug releasing biodegradable fiber for delivery of therapeutics |
| 02/01/2006 | EP1619962A1 Composition for oral administration containing capsaicinoids |
| 02/01/2006 | EP1521535B1 Improved bulking agent composition |
| 02/01/2006 | EP1509202A4 Novel high viscosity embolizing compositions comprising prepolymers |
| 02/01/2006 | EP1487421B1 Pharmaceutical formulation for the active ingredient budesonide |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | EP1343492B1 Treatment of mucositis |
| 02/01/2006 | EP1332148B1 Diamido alkoxides as polymerisation initiators |
| 02/01/2006 | EP1267827B1 Use of an aqueous solution for the treatment of try eye |
| 02/01/2006 | EP1225874B1 Antiviral solid dispersions |
| 02/01/2006 | EP1150675B1 A transdermal composition of an antivomiting agent and a preparation containing the same |
| 02/01/2006 | EP1104289B1 New oral formulation for 5-ht4 agonists or antagonists |
| 02/01/2006 | EP1095162B8 Archiving of vectors |
| 02/01/2006 | EP1001743B1 Implants for controlled release of pharmaceutically active principles and method for making same |
| 02/01/2006 | EP0994695A4 Continuous microsphere process |